Kenta Maeda struggled in the previous season, posting a career-worst 6.09 ERA over 112.1 innings. His signing was viewed as a disappointment, and he will need to rebound to regain his effectiveness in the rotation.

Kenta Maeda struggled in his first season with the Tigers, posting a 6.09 ERA and the lowest strikeout rate of his career. After being moved to the bullpen due to his performance, he showed some improvement but faltered again when given a chance to start in the regular season finale. Despite his challenges, president of baseball operations Scott Harris stated that Maeda will compete for a spot in the rotation in 2025, emphasizing the potential for him to regain his effectiveness. With another $12 million owed, the team has little to lose by allowing him another opportunity to prove himself, though a permanent move to the bullpen or a parting of ways could be considered if he struggles again.

Kenta Maeda struggled significantly during the 2024 season, failing to meet expectations as a mid-rotation starter after signing a two-year, $24 million contract. He produced the worst results among the team's pitchers, finishing with a 6.09 ERA despite attempts by management to improve his performance by having him follow an opener in the second half of the season. His disappointing performance has raised concerns about his future contributions to the team.

Kenta Maeda will not be active for the ALDS, marking his second consecutive series absence. In 2024, he struggled with a 3-7 record and a 6.09 ERA, and the Tigers are hesitant to rely on him after a tumultuous season that saw him shift between the rotation and bullpen. Despite his playoff experience, with a career 3.24 ERA in 27 postseason appearances, the team is opting for other options at this time. Maeda is scheduled to throw bullpen sessions to stay prepared for any potential injury replacements.

Maeda was a reliable starter for the Dodgers from 2016 to 2019 before signing with the Minnesota Twins, where he had a standout season in 2020. After undergoing Tommy John surgery, he signed a two-year deal with the Tigers. Struggling as a starter early in the season, he transitioned to the bullpen and showed reasonable effectiveness. However, he was left off the wild-card roster, raising questions about his potential activation for the American League Division Series. Maeda is under contract for $10 million in 2025.